Search Results
Groundbreaking Hope for Moderate-to-Severe Plaque Psoriasis Patients
Targeting the Burden of Moderate to Severe Psoriasis
New Medication Shows Early Promise for Psoriasis Patients
Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment
Long-term efficacy and safety of tildrakizumab, K. Reich et al
Hope for Psoriasis | Living Minute
Triggering Factors and Assessing Severity of Plaque Psoriasis
Psoriasis: Enbrel, Humira, Cosyntx, Tremfya and others
Tildrakizumab: the Patient Journey
QD154 - Paradoxical Psoriasis
WATCH NOW: Why New Treatments are Needed for the Management of Psoriasis
Benjamin Lockshin, MD - Biologics for patients with severe psoriasis and a history of lymphoma?
